关于重组乙肝表面抗原纯化收率的研究

本文采用回归分析法研究了超速离心纯化时,固定一次溴化钾密度梯度比例,选择不同的二次溴化钾梯度比例对下一步ＳｅｐｈａｒｏｓｅＣＬ－４Ｂ柱层析纯化收率的影响。结果表明：回归分析不仅能揭示纯化的最佳条件,即,二次溴化钾超速离心时溶液由２４０ｍｌ（１．０４ｇ／ｍｌ）：８００ｍ１（１．２８ｇ／ｍｌ）：６００ｍｌ（１．３２ｇ／ｍｌ）：５０ｍｌ（１．３４ｇ／ｍｌ）构成时柱层析收率最高。而且还能解释层析纯化中出现的异常结果。     

高效价甘薯羽状斑驳病毒抗血清的制备

用嫁接方法将甘薯羽状斑驳病毒（ＳＰＦＭＶ）接种到Ｉ．ｓｅｔｏｓａ上扩繁,以０．２ｍｏｌ／ＬｐＨ７．２ＰＢＫ缓冲液、垫层差速离心、蔗糖密度梯度离心提取纯化ＳＰＦＭＶ。纯化的ＳＰＦＭＶＯＤ２６０／２８０的比值为１．２５。将纯化的ＳＰＦＭＶ免疫家兔制备抗血清,在环状沉淀和微量沉淀试验中,用提纯病毒测定抗血清的效价均为１：４０９６;以ＳＰＦＭＶ－ＩｇＧ为第一抗体,应用Ｄｏｔ－ＥＬＩＳＡ对甘薯和Ｉ．ｓｅｌｏｓａ叶片中的ＳＰＦＭＶ分别作了测定。     

地衣芽孢杆菌β－甘露聚糖酶的纯化及酶学性质

地衣芽孢杆菌（Ｂａｃｉｌｌｕｓｌｉｃｈｅｎｉｆｏｒｍｉｓ）ＮＫ－２７菌株发酵产生的β－甘露聚糖酶（β－ｍａｎｎａｎａｓｅ）经硫酸铵盐析沉淀,两次ＤＥＡＥ纤维素和ＳｅｐｈａｄｅｘＧ－１００离子交换柱层析以及制备ＰＡＧＥ筹步骤,获得了凝胶电泳均一的样品。用ＳＤＳ－凝胶电泳测得纯化后的β－甘露聚糖酶分子量为２６ｋＤ,用凝胶聚焦电泳测得等电点ＰＩ为５．０。酶反应的最适ｐＨ为９．０,最后温度为６０℃,稳定ｐＨ为６．０—９．０,稳定温度为４０℃。金属离子中Ｍｇ￣（２＋）、Ｃａ￣（２＋）、Ｆｅ￣（２＋）、Ｎｉ￣（２＋）对该酶有一定的激活作用;而Ｓｎ￣（２＋）、Ｚｎ￣（２＋）、Ａｌ￣（３＋）、Ａｇ￣＋和Ｈｇ￣（２＋）对该酶有强烈的抑制作用。ＮＫ－２７菌株的β－甘露聚糖酶对魔芋葡萄甘露聚糖和角豆胶半乳甘露聚糖的Ｋｍ值分别为７．１４和５．５６ｍｇ·ｍｌ￣（－１）;Ｖ＿（ｍａｘ）分别为２００．５３和１５７．４５μｍｏｌ·ｍｇ￣（－１）·ｍｉｎ￣（－１）。     

细胞分裂素的混合抗体型免疫亲和柱的制备与应用

内源细胞分裂素可以分成三组：异戊烯基腺苷组（ｉＰＡｓ）、玉米素核苷组（ＺＲｓ）、二氢玉米素核苷组（ＤＨＺＲｓ）。从这三组分别选ｉＰＡ、ＺＲ、ＤＨＺＲ为半抗原合成免疫原,获得的三种免抗血清基本上只识别相应组的细胞分裂素。将经初纯化的三种抗血清偶联到ＣＮＢｒ活化的Ｓｅｐｈａｒｏｓｅ４Ｂ上制成免疫亲和柱。在其中的一根柱床高２．１ｃｍ、体积３．５５ｍｌ、直径１．５ｃｍ的亲和柱上,在流速１．５ｍｌ／ｍｉｎ、８０％冷甲醇为洗脱剂的条件下测得该柱容量为３．６—４．０μｇ、回收率达９３．９％～９８．３％。用该柱对丝瓜茎木质部伤流中细胞分裂素进行了纯化．表明能够用此柱对植物粗提液中的细胞分裂素进行快速分离纯化。     

人突变appE基因在转基因鼠体内的表达及血清脂质变化

为了研究人突变ａｐｏＥ７基因在血脂代谢中的作用．采用微注射的方法建立了人ａｐｏＥ７转基因鼠,三个首建鼠（ｔｇ１,ｔｇ２,ｔｇ３）整合目的基因的拷贝数相差２倍左右,其血中表达的人ａｐｏＥ７的水平也不相同,低水平表达的ｔｇ１为１．２６ｍｇ／ｄｌ,高水平表达的首建鼠ｔｇ３血清中ａｐｏＥ７浓度可高达２１．１ｍｇ／ｄｌ．异常ａｐｏＥ基因的表达导致了转基因鼠血清甘油三酯和胆固醇明显升高,为对照的１．５～３倍．高密度脂蛋白ＨＤＬ降低,低密度脂蛋白ＬＤＬ和极低密度脂蛋白ＶＬＤＬ升高．经２０ｍｍｏｌ／ＬＺｎＳＯ４诱导后,Ｆ１代Ｔｇ３鼠系血清甘油三酯（ＴＧ）水平高达４４４ｍｇ／ｄｌ,胆固醇（ＴＣ）高达２３４ｍｇ／ｄ１．ＨＤＬ升高和ＬＤＬ／ＶＬＤＬ降低十分明显,表现了高脂血症的指征．     

白细胞介素-1β对骨髓基质细胞膜电位及细胞内Ca2+和pH的影响

采用荧光染料 Ｄｉ Ｂ Ａ Ｃ４（３）, Ｆｌｕｏ３／ Ａ Ｍ 和 Ｓ Ｎ Ａ Ｌ Ｆ Ｃａｌｃｅｉｎ／ Ａ Ｍ 分别标记小鼠骨髓基质细胞（ Ｂ Ｍ Ｓ Ｃ）,在激光扫描共聚焦显微镜下直接监测重组人白细胞介素１β（ Ｉ Ｌ１β）刺激后细胞膜电位,细胞内游离 Ｃａ２＋ 浓度和胞浆 ｐ Ｈ 的实时动态变化． 结果发现： Ｉ Ｌ１β加入测定体系后浓度依赖性地引起 Ｂ Ｍ Ｓ Ｃ 膜电位的迅速改变． 低浓度时发生去极化反应,高浓度时发生超极化反应． 非受体方式作用的 Ｉ Ｌ１β肽段 １６３１７１ 对膜电位无影响． Ｉ Ｌ１β不影响细胞内 Ｃａ２＋ 的浓度和胞浆ｐ Ｈ． 研究表明膜电位的变化为 Ｉ Ｌ１ 受体后早期事件,它与细胞内 Ｃａ２＋的浓度和胞浆 ｐ Ｈ 的调节无关．     

地衣芽孢杆菌β—甘露聚糖酶的纯化及酶学性质

地衣芽孢杆菌（Ｂａｃｉｌｌｕｓ ｌｉｃｈｅｎｉｆｏｒｍｉｓ）ＮＫ－２７菌株发酵产生的β－甘露聚糖酶（β－ｍａｎｎａｎａｓｅ）经硫酸铵盐析沉淀,两次ＤＥＡＥ纤维素和Ｓｅｐｈａｄｅｘ Ｇ－１００离子交换柱层析以及制备ＰＡＧＥ等步骤,获得了凝胶电泳均一的样品。用ＳＤＳ－凝胶电泳测得纯化后的β－甘露聚糖酶分子量为２６ｋＤ,用凝胶聚焦电泳测得等电点Ｐ１为５．０。酶反应的最适ｐＨ为９．０,最适温度为６０℃,稳     

水稻条纹病毒病害特异蛋白的提纯及血清学特性

应用差别ｐ Ｈ 值沉淀蛋白质的原理,建立了水稻条纹病毒病特异蛋白（ Ｓ Ｐ） 的两种提纯方法。这两种方法都可以从病叶中提纯到大量的 Ｓ Ｐ,其粗提纯量分别为０ ．８ 和２ ．０ ｍｇ／ｇ 病叶。通过 Ｓ Ｄ Ｓ Ｐ Ａ Ｇ Ｅ 分离后得到了精提纯的蛋白,其分子量为２０ ．１ ｋ Ｄａ 。将粗提纯和精提纯的 Ｓ Ｐ 分别免疫兔子,制备出效价为５１ ２００ 和６ ４００ 的抗血清。将效价为６ ４００ 的高度特异性的抗血清用于研究 Ｒ Ｓ Ｖ Ｓ Ｐ 与 Ｒ Ｓ Ｖ Ｃ Ｐ 及同属的水稻草状矮化病毒（ Ｒ Ｇ Ｓ Ｖ） Ｓ Ｐ、 Ｃ Ｐ 之间的血清学关系,结果表明, Ｒ Ｓ Ｖ Ｓ Ｐ 的抗血清与 Ｒ Ｇ Ｓ Ｖ Ｃ Ｐ、 Ｒ Ｓ Ｖ Ｃ Ｐ 之间无反应,但可与 Ｒ Ｇ Ｓ Ｖ Ｓ Ｐ 微弱反应;而 Ｒ Ｇ Ｓ Ｖ Ｓ Ｐ、 Ｃ Ｐ 及 Ｒ Ｓ Ｖ Ｃ Ｐ 的抗血清与 Ｒ Ｓ Ｖ Ｓ Ｐ 之间都无血清学反应。结果证实了 Ｒ Ｓ Ｖ 和 Ｒ Ｇ Ｓ Ｖ 之间存在着进化上的亲缘关系     

细菌转化黑色素的抗流感病毒作用

采用敏感的ＭＴＴ法测定了嗜麦芽假单胞菌转化黑色素的抗流感病毒作用。测定结果表明：纯化的黑色素毒性极低,对ＭＤＣＫ细胞的无毒界限为０．２ｍｇ／ｍｌ,远高于其有效的作用浓度;１０～２０μｇ／ｍｌ的黑色素能有效抑制流感病毒（血凝效价１∶３２）致细胞病变。病毒感染７２ｈ后用ＭＴＴ法测定,其宿主ＭＤＣＫ细胞保护百分率达９５％以上;此外,加黑色素后的ＭＤＣＫ细胞,抗流感病毒感染的能力优于目前抗病毒的有效药物病毒唑,前者的最佳作用浓度（２０μｇ／ｍｌ）比后者（１００μｇ／ｍｌ）低５倍。可以认为嗜麦芽假单胞菌转化黑色素具有毒性低、抗流感病毒能力强的特点     

地衣芽孢杆菌β—甘露聚糖酶的纯化及其性质的研究

地衣芽孢杆菌１Ｂａｃｉｕｕｓ Ｌｉｃｈｅｎｉｆｏｒｍｉｓ）ＢＬ－３０６产生的胞外β－甘露聚糖酶经硫酸铵分级盐析,ＤＥＡＥ－纤维素柱层析。Ｓｅｐｈａｄｅｘ－Ｇ１００柱凝胶过滤和ＤＥＡＥ－纤维素柱再层析分离纯化,得到ＳＤＳ－聚丙烯酰胺凝胶电泳（ＳＤＳ－ＰＡＧＥ）均一样品。用ＳＤＳ－ＰＡＧＥ测得纯化后β－甘露聚糖酶分子量为２６０００道尔顿。用凝胶等电聚焦电泳（ＰＡＧＥＩＥＦ）测得等电点ＰＩ为５．０。该酶     

Evaluation of a new apolipoprotein(a) isoform-independent assay for serum Lipoprotein(a)

The risk factor, Lipoprotein(a), [(Lp(a)], has been measured in numerous clinical studies by a variety of immunochemical assay methods. It is becoming apparent that for many of these assays antibody specificity towards the apolipoprotein(a) [apo(a)] repetitive component [the kringle 4 - type 2 repeats] and apo(a) size heterogeneity can significantly affect the accuracy of serum Lp(a) measurements. To address this issue, we investigated whether our current in house Lp(a) [Mercodia] assay showed such bias compared to a recently available assay [Apo-Tek], claiming to possess superior capability for isoform-independent measurement of Lp(a). Levels of Lipoprotein(a) by both Apo-Tek and Mercodia assays correlated inversely with apo(a) isoform sizes. No significant differences were observed between assays in ranges of Lp(a) concentration within each isoform group. The Mercodia assay exhibited similar isoform-independent behaviour to that of Apo-Tek for e quantitation of serum Lipoprotein(a). Essentially identical results were obtained by the two methods, suggesting that Mercodia assay's capture monoclonal antibody also (as is the case for Apo-Tek) does not recognize the kringle 4-type 2 repetitive domain of apo(a). Correlation of Lp(a) concentrations in patient specimens between Apo-Tek and Mercodia assays showed good agreement, although an overall higher degree of imprecision and non-linearity was noted for the Apo-Tek procedure. A change-over to the Apo-Tek assay would therefore not improve on our current assessment of risk contribution from Lp(a) for atherosclerotic vascular disease in individuals with measurable levels of circulating Lipoprotein(a).     

Simple and rapid procedure for the purification of lipoprotein(a)

Lipoprotein(a) [Lp(a)] is a low-density lipoprotein-like particle displaying strong athero-thrombotic properties. Highly purified Lp(a) is increasingly requested for standardization of Lp(a) measurements and for biological studies. Several procedures have been described for Lp(a) separation and purification but none of them appear completely suitable. We present here a procedure for Lp(a) purification based on sequential elutions after lysine-Sepharose affinity chromatography. We were able to identify four distinct subspecies of Lp(a) showing different affinity to ε-amino groups of lysine-Sepharose, simply by modifying molarity and pH of the eluents; the fraction obtained in highly purified state represented the major form and could be eluted with 0.5 M sodium phosphate buffer (pH 4.4). Advantages of this procedure are represented by simplicity, rapidity and final yield.     

脂蛋白（a）的研究进展──生物化学与分子生物学方面

脂蛋白（ａ）［Ｌｐ（ａ）］是一种与低密度脂蛋白类似的脂蛋白,其特殊处在于多含一种具明显多态性的糖蛋白──载脂蛋白（ａ）［Ａｐｏ（ａ）］。Ａｐｏ（ａ）与血浆纤溶酶原有很大同源性。Ｌｐ（ａ）由肝合成,其分解可能主要经非特异途径。Ａｐｏ（ａ）大小及血浆Ｌｐ（ａ）浓度主要由Ａｐｏ（ａ）基因决定。Ｌｐ（ａ）易沉积于血管壁,并可促进平滑肌细胞生长及抑制纤维蛋白溶解,这可能是其促动脉粥样硬化和血栓形成的机理所在。Ｌｐ（ａ）的生理功能尚不清楚。     

A role for apolipoprotein(a) in protection of the low-density lipoprotein component of lipoprotein(a) from copper-mediated oxidation

Low-density lipoprotein (LDL) oxidation is stimulated by copper. Addition of a recombinant form of apolipoprotein(a) (apo(a); the distinguishing protein component of lipoprotein(a)) containing 17 plasminogen kringle IV-like domains (17K r-apo(a)) protects LDL against oxidation by copper. Protection is specific to apo(a) and is not achieved by plasminogen or serum albumin. When Cu(2+) is added to 17K r-apo(a), its intrinsic fluorescence is quenched in a concentration-dependent and saturable manner. Quenching is unchanged whether performed aerobically or anaerobically and is reversible by ethylenediaminetetraacetate, suggesting that it is due to equilibrium binding of Cu(2+) and not to oxidative destruction of tryptophan residues. The fluorescence change exhibits a sigmoid dependence on copper concentration, and time courses of quenching are complex. At copper concentrations below 10 microM there is little quenching, whereas above 10 microM quenching proceeds immediately as a double-exponential decay. The affinity and kinetics of copper binding to 17K r-apo(a) are diminished in the presence of the lysine analogue epsilon -aminocaproic acid. We propose that copper binding to the kringle domains of 17K is mediated by a His-X-His sequence that is located about 5A from the closest tryptophan residue of the lysine binding pocket. Copper binding may account for the natural resistance to copper-mediated oxidation of lipoprotein(a) relative to LDL that has been previously reported and for the protection afforded by apo(a) from copper-mediated oxidation of LDL that we describe in the present study.     

Lipoprotein(a) accelerates atherosclerosis in uremic mice

Uremic patients have increased plasma lipoprotein(a) [Lp(a)] levels and elevated risk of cardiovascular disease. Lp(a) is a subfraction of LDL, where apolipoprotein(a) [apo(a)] is disulfide bound to apolipoprotein B-100 (apoB). Lp(a) binds oxidized phospholipids (OxPL), and uremia increases lipoprotein-associated OxPL. Thus, Lp(a) may be particularly atherogenic in a uremic setting. We therefore investigated whether transgenic (Tg) expression of human Lp(a) increases atherosclerosis in uremic mice. Moderate uremia was induced by 5/6 nephrectomy (NX) in Tg mice with expression of human apo(a) (n = 19), human apoB-100 (n = 20), or human apo(a) + human apoB [Lp(a)] (n = 15), and in wild-type (WT) controls (n = 21). The uremic mice received a high-fat diet, and aortic atherosclerosis was examined 35 weeks later. LDL-cholesterol was increased in apoB-Tg and Lp(a)-Tg mice, but it was normal in apo(a)-Tg and WT mice. Uremia did not result in increased plasma apo(a) or Lp(a). Mean atherosclerotic plaque area in the aortic root was increased 1.8-fold in apo(a)-Tg (P = 0.025) and 3.3-fold (P = 0.0001) in Lp(a)-Tg mice compared with WT mice. Plasma OxPL, as detected with the E06 antibody, was associated with both apo(a) and Lp(a). In conclusion, expression of apo(a) or Lp(a) increased uremia-induced atherosclerosis. Binding of OxPL on apo(a) and Lp(a) may contribute to the atherogenicity of Lp(a) in uremia.     

脂蛋白(a)与动脉粥样硬化及脑梗死的研究进展

脂蛋白(a)是由载脂蛋白(a)和低密度脂蛋白构成的。脂蛋白(a)不随血浆中同型半胱氨酸、载脂蛋白A、高密度脂蛋白的变化而变化,是一种相对独立的脂蛋白。脂蛋白(a)的合成过程主要是在肝脏中完成的,脂蛋白(a)可以抑制NO介导的血管舒张,破坏血管壁中促凝与抗凝因子的平衡,参与动脉粥样硬化斑块的形成。动脉粥样硬化是脑梗死最基本的病因之一,在临床工作中我们应当重视脂蛋白(a)与脑梗死的关系,我们可以通过测定血清中脂蛋白(a)的水平来预测脑梗死的患病风险,尤其能对病变损害程度重,病变累及范围广的脑梗死的发生提出预警。高水平的血浆脂蛋白(a)是脑梗死及动脉粥样硬化的独立危险因素,本文就脂蛋白(a)与动脉粥样硬化及脑梗死研究中的进展做一综述,为脑梗死的预防提供参考和研究依据。     

人血清脂蛋白(a)中纤维蛋白溶酶原位点测定

用单克隆抗载脂蛋白(a)抗体为包被抗体,酶标抗纤维蛋白溶酶原(Pg)抗体为检测抗体建立了人血清脂蛋白(a)［Lp(a)］中Pg位点的酶联免疫吸附试验法.方法特异,测定范围为28～880 mg/L,变异系数批内为4%～6%,批间为7%～9%.检测了正常人、冠心病(CHD)和肾衰血透患者(CRF)血清Lp(a)、Lp(a)中Pg位点和Pg/Lp(a)比值.结果示正常人血清Lp(a)水平分别同Pg、Pg/Lp(a)呈正、负相关.CHD和CRF患者Lp(a)、Pg位点和Pg/Lp(a)比值明显高于正常人,认为Lp(a)中Pg位点测定对于动脉粥样硬化的病理生理研究具有特殊的价值.     

IL-6 and lipoprotein(a) [LP(a)] concentrations are related only in patients with high APO(a) isoforms in monoclonal gammopathy

We have investigated the influence of apo(a) genetics on the relationship between interleukin (IL)-6, and lipoprotein (a) [Lp(a)] levels in 154 patients with monoclonal gammopathy and 189 healthy subjects. No significant differences in Lp(a) levels and distribution of subjects with different sizes of apo(a) isoforms were found between patients and healthy controls. Relationship between IL-6 and Lp(a) levels was strongly dependent on the size of apo(a) isoforms. In patients with high-size apo(a) isoforms Lp(a) levels positively correlated (r=0.475, P=0.0007) to IL-6 concentrations, whereas no correlation was found in patients with low apo(a) isoforms. Our present finding may provide a plausible explanation for the contradictory findings about the acute phase protein nature of Lp(a).